domperidone has been researched along with indazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CS; Chang, LC; Hsu, MF; Huang, LJ; Huang, TH; Lee, PW; Lin, RH; Tsai, YR; Wang, JP | 1 |
| Aoyama, M; Hirano, H; Ishikawa, K; Nemoto, S; Osada, H; Semba, K; Watanabe, N; Watanabe, S | 1 |
2 other study(ies) available for domperidone and indazoles
| Article | Year |
|---|---|
Signaling mechanisms of inhibition of phospholipase D activation by CHS-111 in formyl peptide-stimulated neutrophils.
Topics: ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Animals; Cardiac Myosins; Carrier Proteins; Cell Degranulation; Cell Movement; Domperidone; Enzyme Activation; Indazoles; Indoles; Myosin Light Chains; Neutrophils; Phospholipase D; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2011 |
Lonidamine and domperidone inhibit expansion of transformed cell areas by modulating motility of surrounding nontransformed cells.
Topics: Animals; Antineoplastic Agents; Domperidone; Drug Screening Assays, Antitumor; Epithelial Cells; Indazoles; Mammary Glands, Animal; Mice; Neoplasms | 2022 |